119th Congress
H.R. 8339
Drug Origin Transparency Act of 2026
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Doris O. Matsui(D-CA)
- Introduced
- Apr 16, 2026
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (3)
Original cosponsors (3)
- Ashley Hinson (R-IA)
- Dan Crenshaw (R-TX)
- Kim Schrier (D-WA)
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.
Latest action(Apr 16, 2026): Referred to the House Committee on Energy and Commerce.
Roll-call votes
No recorded votes on this bill.
Actions
- Apr 16, 2026 · House
Referred to the House Committee on Energy and Commerce. - Apr 16, 2026
Introduced in House